Published • loading... • Updated
Esperovax Announces U.S. Patent Allowance for In Vivo Therapeutic Protein Expression Platform
Summary by Lake Geneva News
2 Articles
2 Articles
Lake Geneva NewsReposted by 
WJFW NewsWatch 12
WJFW NewsWatch 12Esperovax Announces U.S. Patent Allowance for In Vivo Therapeutic Protein Expression Platform
PLYMOUTH, Mich., Sept. 11, 2026 /PRNewswire/ -- Esperovax, Inc. today announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. Patent Application No. 18/038,673, entitled "Yeast-Based Expression of Therapeutic Proteins In Vivo."
Coverage Details
Total News Sources2
Leaning Left0Leaning Right1Center1Last UpdatedBias Distribution50% Center, 50% Right
Bias Distribution
- 50% of the sources are Center, 50% of the sources lean Right
50% Right
C 50%
R 50%
Factuality
To view factuality data please Upgrade to Premium
